Search Results - "Fauty, Scott E."

  • Showing 1 - 5 results of 5
Refine Results
  1. 1

    Physicochemical properties, form, and formulation selection strategy for a biopharmaceutical classification system class II preclinical drug candidate by Lohani, Sachin, Cooper, Harriet, Jin, Xiaoling, Nissley, Becky P, Manser, Kimberly, Rakes, Linda Huong, Cummings, John J, Fauty, Scott E, Bak, Annette

    Published in Journal of pharmaceutical sciences (01-10-2014)
    “…This work summarizes the pharmaceutical evaluation of a preclinical drug candidate with poor physicochemical properties. Compound 1 is a weakly basic, GPR-119…”
    Get more information
    Journal Article
  2. 2

    Combined Use of Crystalline Sodium Salt and Polymeric Precipitation Inhibitors to Improve Pharmacokinetic Profile of Ibuprofen through Supersaturation by Terebetski, Jenna L., Cummings, John J., Fauty, Scott E., Michniak-Kohn, Bozena

    Published in AAPS PharmSciTech (01-10-2014)
    “…To maximize the pharmacological effect of a pain reliever such as ibuprofen, early onset of action is critical. Unfortunately, the acidic nature of ibuprofen…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Administration of Fenofibrate Markedly Elevates Fabp3 in Rat Liver and Plasma and Confounds Its Use as a Preclinical Biomarker of Cardiac and Muscle Toxicity by Kochansky, Christopher J., Lyman, Michael J., Fauty, Scott E., Vlasakova, Katerina, D'mello, Anil P.

    Published in Lipids (01-10-2018)
    “…Proteins involved in lipid homeostasis are often regulated through the nuclear peroxisome proliferator‐activated receptors (PPAR). PPARα is the target for the…”
    Get full text
    Journal Article
  5. 5